Syncona Partners LLP
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Syncona Partners LLP is a healthcare company focused on investing in and building global leaders in life science.
Investor Profile
Syncona Partners LLP has made 46 investments, with 6 in the past 12 months and 59% as lead.
Stage Focus
- Series A (39%)
- Series B (33%)
- Seed (11%)
- Series C (11%)
- Private Equity (2%)
- Post Ipo Equity (2%)
- Series Unknown (2%)
Country Focus
- United Kingdom (76%)
- United States (15%)
- Switzerland (7%)
- The Netherlands (2%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Life Science
- Biopharma
- Pharmaceutical
- Health Diagnostics
- Genetics
- Wellness
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
